News on haematological malignancies
New test predicts immune effector cell-associated neurotoxicity syndrome
Medical researchers in Japan have discovered a way to predict immune effector cell-associated neurotoxicity syndrome,…
Browsing: Haematology
When blood cancer starts to spread
When blood cancer cells break through the bone and multiply, tumour cells become dangerously diverse…
New guidelines for managing blood cancers in pregnancy
A new set of guidelines has been developed to assist with the diagnosis and expert…
New cellular immunotherapy approach shows promise for B-cell lymphoma
A new type of cell-based immunotherapy shows promise for B-cell lymphomas and — due to…
ASH 2024: A fibre-rich diet may help prevent complications after stem cell transplant
Consuming a high-fiber diet after undergoing stem cell transplantation could help to reduce the risk…
ASH 2024: Study reveals how venetoclax boosts immune response to CAR T for chronic lymphocytic leukaemia
Research out of Roswell Park Comprehensive Cancer Center has shed light on how the drug…
ASH 2024: High-fibre diet may slow disease progression in multiple myeloma
New data suggest that a plant-based diet rich in fibre could help to improve the…
ASH 2024: Prospective study finds social and economic factors limit access to stem cell transplants for patients with AML
Many patients with acute myeloid leukemia (AML) can be cured by a transplant of blood-forming…
ASH 2024: Longer-term data for asciminib reinforce superior efficacy with favourable safety and tolerability profile in adults with newly diagnosed CML
Novartis today announced positive, longer-term results from the pivotal Phase III ASC4FIRST trial with asciminib…
ASH 2O24: Early signs of efficacy for a novel drug and a new predictive tool to guide patient care
Dana-Farber Cancer Institute researchers (USA) are breaking new ground in the fight against systemic mastocytosis,…